GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Integrated Signaling in Pancreatic Cancer Progression

$366,000
Robert S Bresalier · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA

Integrated Signaling in Pancreatic Cancer Progression

$366,000
Keping Xie · University Of Tx Md Anderson Can Ctr · R01 · FY2016 · CA

Clinical Significance of Pancreatic Cancer Differentiation and Dedifferentiation

$366,000
Keping Xie · University Of Tx Md Anderson Can Ctr · R01 · FY2016 · CA

The molecular mechanisms of metabolism reprogramming in mutant Kras/Ink4a-driven pancreatic ductal adenocarcinoma

$366,000
Paul J Chiao · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · CA

PEA15 IN DEVELOPMENT OF LIVER CANCER AND ITS THERAPEUTIC IMPLICATION

$365,994
Ju-Seog Lee · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA

Molecular Mechanisms of Acute Pancreatitis

$365,981
Craig D Logsdon · University Of Tx Md Anderson Can Ctr · R01 · FY2009 · DK

A novel therapy for pancreatic neuroendocrine tumors

$365,962
Asfar S Azmi · Wayne State University · R01 · FY2020 · CA

Radio-immunotherapy to Target Cancer Stem Cells in Solid Tumor Malignancies

$365,919
William Joseph Murphy · University Of California At Davis · R01 · FY2017 · CA

Radio-immunotherapy to Target Cancer Stem Cells in Solid Tumor Malignancies

$365,919
William Joseph Murphy · University Of California At Davis · R01 · FY2018 · CA

Project 3: The Functional Contribution of Tumor Immunity in PDAC

$365,868
Raghu Kalluri · University Of Tx Md Anderson Can Ctr · P01 · FY2016 · CA

Studying the initiation, progression and therapy of lung cancer in mouse models

$365,750
Martin McMahon · University Of Utah · R01 · FY2024 · CA

Radio-immunotherapy to Target Cancer Stem Cells in Solid Tumor Malignancies

$365,534
William Joseph Murphy · University Of California At Davis · R01 · FY2016 · CA

Treatment of Hypoxia Resistance in Pancreatic Cancer - Clinical

$365,488
Translational Genomics Research Inst · P01 · FY2005 · CA

Animal Core Facility

$365,400
Bin Guo · North Dakota State University · P20 · FY2019 · GM

Molecular Epidemiology of Pancreatic Cancer

$365,238
Paige M. Bracci · University Of California, San Francisco · R01 · FY2009 · CA

Microbial- based targeting of major extracellular matrix components for improved therapy of pancreatic cancer

$365,200
Edwin Manuel · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA

Targeting tumor and its microenvironment using nanotherapeutics for pancreatic cancer

$365,189
Satyanarayana Rachagani · University Of Nebraska Medical Center · R01 · FY2022 · CA

Basic Science Research in Digestive Diseases

$365,177
Mark Donowitz · Johns Hopkins University · T32 · FY2012 · DK

Ultrasenstive vesicle analysis in precancerous pancreatic neoplasm (IPMN)

$365,086
Ralph Weissleder · Massachusetts General Hospital · R01 · FY2024 · CA

Type I Interferon Pathway in Pancreatic Adenocarcinoma

$365,086
Serge Y Fuchs · University Of Pennsylvania · R01 · FY2021 · CA

Preclinical development of a novel antibody conjugate for intraoperative detection of pancreatic cancer

$365,076
Aaron M. Mohs · University Of Nebraska Medical Center · R01 · FY2022 · CA

NIA Confocal Imaging Facility

$365,036
Fred Indig · National Institute On Aging · ZIC · FY2016 · AG

Functional Characterization of CCDC130 Gene

$365,000
Deepak Kumar · University Of The District Of Columbia · SC1 · FY2010 · CA

Targeting the autophagy-lysosome system to block pancreatic cancer

$364,912
Rushika Miriam Perera · University Of California, San Francisco · R01 · FY2023 · CA

Targeting the autophagy-lysosome system to block pancreatic cancer

$364,912
Rushika Miriam Perera · University Of California, San Francisco · R01 · FY2022 · CA